Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
暂无分享,去创建一个
M. Rieder | D. Nickerson | J. Emerson | R. Gibson | M. Bamshad | M. Emond | K. Barnes | T. Louie | H. Tabor | R. Mathias | J. Chong | M. Knowles | Lung Go | Jessica X. Chong
[1] Andriy Derkach,et al. Association analysis using next-generation sequence data from publicly available control groups: the robust variance score statistic , 2014, Bioinform..
[2] F. Accurso,et al. Cystic fibrosis transmembrane conductance regulator and pseudomonas. , 2014, American journal of respiratory and critical care medicine.
[3] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[4] K. Claes,et al. Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients. , 2012, Human immunology.
[5] J. Emerson,et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[6] M. Rieder,et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.
[7] G. Cutting,et al. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. , 2012, The Journal of pediatrics.
[8] M. Rieder,et al. Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis , 2012, Nature Genetics.
[9] L. Dupré,et al. EVER Proteins, Key Elements of the Natural Anti-Human Papillomavirus Barrier, Are Regulated upon T-Cell Activation , 2012, PloS one.
[10] Fred A. Wright,et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 , 2011, Nature Genetics.
[11] M. Drumm,et al. Phospholipase C-β3 Is a Key Modulator of IL-8 Expression in Cystic Fibrosis Bronchial Epithelial Cells , 2011, The Journal of Immunology.
[12] P. Paré,et al. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis , 2011, Pediatric pulmonology.
[13] Y. Nikolsky,et al. Interactions between an inflammatory response to infection and protein trafficking pathways favor correction of defective protein trafficking in Cystic Fibrosis , 2010, Bioinformation.
[14] J. Clancy,et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. , 2010, The New England journal of medicine.
[15] J. Wright,et al. The expanding roles of caveolin proteins in microbial pathogenesis , 2009, Communicative & integrative biology.
[16] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[17] Margaret Rosenfeld,et al. Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. , 2009, Contemporary clinical trials.
[18] M. Gadjeva,et al. Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. , 2009, American journal of physiology. Cell physiology.
[19] S. Randell,et al. Counteracting Signaling Activities in Lipid Rafts Associated with the Invasion of Lung Epithelial Cells by Pseudomonas aeruginosa* , 2009, Journal of Biological Chemistry.
[20] D. Rotin,et al. High-content Functional Screen to Identify Proteins that Correct F508del-CFTR Function*S , 2009, Molecular & Cellular Proteomics.
[21] Yuri Nikolsky,et al. MetaMiner (CF): a disease-oriented bioinformatics analysis environment. , 2009, Methods in molecular biology.
[22] M. Favre,et al. Role of Zn2+ Ions in Host-Virus Interactions , 2008, Journal of Virology.
[23] M. Corey,et al. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. , 2008, The Journal of clinical investigation.
[24] M. Ozbun,et al. Human Papillomavirus Type 31 Uses a Caveolin 1- and Dynamin 2-Mediated Entry Pathway for Infection of Human Keratinocytes , 2007, Journal of Virology.
[25] M. Konstan,et al. Inflammation and anti-inflammatory therapies for cystic fibrosis. , 2007, Clinics in chest medicine.
[26] A. Wiik,et al. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[27] C. Goss,et al. CFTR genotype as a predictor of prognosis in cystic fibrosis. , 2006, Chest.
[28] L. Dupont,et al. Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre , 2006, European Respiratory Journal.
[29] G. Döring,et al. Eradication of Pseudomonas aeruginosa in cystic fibrosis patients , 2006, European Respiratory Journal.
[30] Michael R Knowles,et al. Genetic modifiers of lung disease in cystic fibrosis. , 2005, The New England journal of medicine.
[31] J. Wright,et al. Pseudomonas Invasion of Type I Pneumocytes Is Dependent on the Expression and Phosphorylation of Caveolin-2* , 2005, Journal of Biological Chemistry.
[32] M. Kosorok,et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. , 2005, JAMA.
[33] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[34] Gordon Johnston,et al. Statistical Models and Methods for Lifetime Data , 2003, Technometrics.
[35] D. Lowy,et al. Papillomaviruses infect cells via a clathrin-dependent pathway. , 2003, Virology.
[36] M. Denton,et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[37] J. Emerson,et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.
[38] J. Emerson,et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.
[39] Matthew R. Parsek,et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms , 2000, Nature.
[40] L. Schwichtenberg,et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. , 2000, American journal of respiratory cell and molecular biology.
[41] P. J. Byard,et al. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. , 1995, Journal of clinical epidemiology.
[42] C. Mellis,et al. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis , 1992, Pediatric pulmonology.
[43] D. Harrington,et al. Counting Processes and Survival Analysis , 1991 .